Blueprint Medicines Corp Probability of Future Stock Price Finishing Over 133.19
| BPMCDelisted Stock | USD 129.46 0.11 0.09% |
Blueprint |
Blueprint Medicines Target Price Odds to finish over 133.19
The tendency of Blueprint Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 133.19 or more in 90 days |
| 129.46 | 90 days | 133.19 | about 10.77 |
Based on a normal probability distribution, the odds of Blueprint Medicines to move over $ 133.19 or more in 90 days from now is about 10.77 (This Blueprint Medicines Corp probability density function shows the probability of Blueprint Stock to fall within a particular range of prices over 90 days) . Probability of Blueprint Medicines Corp price to stay between its current price of $ 129.46 and $ 133.19 at the end of the 90-day period is nearly 4.34 .
Given the investment horizon of 90 days Blueprint Medicines Corp has a beta of -0.55 suggesting as returns on the benchmark increase, returns on holding Blueprint Medicines are expected to decrease at a much lower rate. During a bear market, however, Blueprint Medicines Corp is likely to outperform the market. Additionally Blueprint Medicines Corp has an alpha of 0.8283, implying that it can generate a 0.83 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Blueprint Medicines Price Density |
| Price |
Predictive Modules for Blueprint Medicines
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Blueprint Medicines Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Blueprint Medicines Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Blueprint Medicines is not an exception. The market had few large corrections towards the Blueprint Medicines' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Blueprint Medicines Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Blueprint Medicines within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.83 | |
β | Beta against Dow Jones | -0.55 | |
σ | Overall volatility | 17.99 | |
Ir | Information ratio | 0.17 |
Blueprint Medicines Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Blueprint Medicines for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Blueprint Medicines Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Blueprint Medicines is not yet fully synchronised with the market data | |
| Blueprint Medicines appears to be risky and price may revert if volatility continues | |
| Blueprint Medicines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 508.82 M. Net Loss for the year was (67.09 M) with profit before overhead, payroll, taxes, and interest of 542.35 M. | |
| Blueprint Medicines Corp currently holds about 853.11 M in cash with (192.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.28. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Blueprint Medicines Reaches New 52-Week High Heres Why |
Blueprint Medicines Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Blueprint Stock often depends not only on the future outlook of the current and potential Blueprint Medicines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Blueprint Medicines' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 62.9 M | |
| Cash And Short Term Investments | 615.5 M |
Blueprint Medicines Technical Analysis
Blueprint Medicines' future price can be derived by breaking down and analyzing its technical indicators over time. Blueprint Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Blueprint Medicines Corp. In general, you should focus on analyzing Blueprint Stock price patterns and their correlations with different microeconomic environments and drivers.
Blueprint Medicines Predictive Forecast Models
Blueprint Medicines' time-series forecasting models is one of many Blueprint Medicines' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Blueprint Medicines' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Blueprint Medicines Corp
Checking the ongoing alerts about Blueprint Medicines for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Blueprint Medicines Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Blueprint Medicines is not yet fully synchronised with the market data | |
| Blueprint Medicines appears to be risky and price may revert if volatility continues | |
| Blueprint Medicines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 508.82 M. Net Loss for the year was (67.09 M) with profit before overhead, payroll, taxes, and interest of 542.35 M. | |
| Blueprint Medicines Corp currently holds about 853.11 M in cash with (192.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.28. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Blueprint Medicines Reaches New 52-Week High Heres Why |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Blueprint Stock
If you are still planning to invest in Blueprint Medicines Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Blueprint Medicines' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |